OpenLB
Open Library of Bioscience

Unveiling the Molecular Mechanism of Diosmetin and its Impact on Multifaceted Cellular Signaling Pathways.

Abstract

Keywords

References

1. Ganeshpurkar A.; Saluja A.K.; The pharmacological potential of rutin. Saudi Pharm J 2017,25(2),149-164 [DOI: 10.1016/j.jsps.2016.04.025]
2. Makhuvele R.; Naidu K.; Gbashi S.; Thipe V.C.; Adebo O.A.; Njobeh P.B.; The use of plant extracts and their phytochemicals for control of toxigenic fungi and mycotoxins. Heliyon 2020,6(10),e05291 [DOI: 10.1016/j.heliyon.2020.e05291]
3. Demir Y.; Ceylan H.; T��rke�� C.; Beydemir ��.; Molecular docking and inhibition studies of vulpinic, carnosic and usnic acids on polyol pathway enzymes. J Biomol Struct Dyn 2022,40(22),12008-12021 [DOI: 10.1080/07391102.2021.1967195]
4. Bayrak S.; ��zt��rk C.; Demir Y.; Al��m Z.; K��frevioglu ��.��.; Purification of polyphenol oxidase from potato and investigation of the inhibitory effects of phenolic acids on enzyme activity. Protein Pept Lett 2020,27(3),187-192 [DOI: 10.2174/0929866526666191002142301]
5. Williams C.A.; Grayer R.J.; Anthocyanins and other flavonoids. Nat Prod Rep 2004,21(4),539-573 [DOI: 10.1039/b311404j]
6. ��zaslan M.S.; Sa��lamta�� R.; Demir Y.; Gen�� Y.; Sara��o��lu ��.; G��l��in ��.; Isolation of some phenolic compounds from plantago subulata l. and determination of their antidiabetic, anticholinesterase, antiepileptic and antioxidant activity. Chem Biodivers 2022,19(8),e202200280 [DOI: 10.1002/cbdv.202200280]
7. Palab��y��k E.; Sulumer A.N.; Uguz H.; Avc�� B.; Ask��n S.; Ask��n H.; Demir Y.; Assessment of hypolipidemic and anti-inflammatory properties of walnut (Juglans regia) seed coat extract and modulates some metabolic enzymes activity in triton WR-1339-induced hyperlipidemia in rat kidney, liver, and heart. J Mol Recognit 2023,36(3),e3004 [DOI: 10.1002/jmr.3004]
8. T��rke�� C.; Demir Y.; Beydemir ��.; In Vitro inhibitory activity and molecular docking study of selected natural phenolic compounds as AR and SDH inhibitors**. ChemistrySelect 2022,7(48),e202204050 [DOI: 10.1002/slct.202204050]
9. Ahmad T.; Javed A.; Khan T.; Althobaiti Y.S.; Ullah A.; Almutairi F.M.; Shah A.J.; Investigation into the antihypertensive effects of diosmetin and its underlying vascular mechanisms using rat model. Pharmaceuticals 2022,15(8),951 [DOI: 10.3390/ph15080951]
10. Song C.; Deng S.; Hu H.; Zheng Z.; Shen B.; Wu X.; Huang M.; Wang J.; Wang Z.; Diosmetin affects gene expression on human lung adenocarcinoma cells. J Oncol 2022,2022,1-9 [DOI: 10.1155/2022/5482148]
11. Yoshikawa M.; Uemura T.; Shimoda H.; Kishi A.; Kawahara Y.; Matsuda H.; Medicinal foodstuffs. XVIII. Phytoestrogens from the aerial part of Petroselinum crispum MIll. (Parsley) and structures of 6"-acetylapiin and a new monoterpene glycoside, petroside. Chem Pharm Bull 2000,48(7),1039-1044 [DOI: 10.1248/cpb.48.1039]
12. Catani M.V.; Rinaldi F.; Tullio V.; Gasperi V.; Savini I.; Comparative analysis of phenolic composition of six commercially available chamomile (Matricaria chamomilla L.) extracts: Potential biological implications. Int J Mol Sci 2021,22(19),10601 [DOI: 10.3390/ijms221910601]
13. Hostetler G.L.; Riedl K.M.; Schwartz S.J.; Endogenous enzymes, heat, and pH affect flavone profiles in parsley (Petroselinum crispum var. neapolitanum) and celery (Apium graveolens) during juice processing. J Agric Food Chem 2012,60(1),202-208 [DOI: 10.1021/jf2033736]
14. Hostetler G.L.; Ralston R.A.; Schwartz S.J.; Flavones: Food sources, bioavailability, metabolism, and bioactivity. Adv Nutr 2017,8(3),423-435 [DOI: 10.3945/an.116.012948]
15. Gattuso G.; Barreca D.; Gargiulli C.; Leuzzi U.; Caristi C.; Flavonoid composition of Citrus juices. Molecules 2007,12(8),1641-1673 [DOI: 10.3390/12081641]
16. Villalva M.; Silvan J.M.; Alarc��n-Cavero T.; Villanueva-Bermejo D.; Jaime L.; Santoyo S.; Martinez-Rodriguez A.J.; Antioxidant, anti-inflammatory, and antibacterial properties of an Achillea millefolium L. Extract and its fractions obtained by supercritical anti-solvent fractionation against Helicobacter pylori. Antioxidants 2022,11(10),1849 [DOI: 10.3390/antiox11101849]
17. Lee DH; Park JK; Choi J; Jang H; Seol JW; Anti-inflammatory effects of natural flavonoid diosmetin in IL-4 and LPS-induced macrophage activation and atopic dermatitis model. Int Immunopharmacol 2020,89,107046 [DOI: 10.1016/j.intimp.2020.107046]
18. Barton NW; Lipovac V; Rosenberg A; Effects of strong electrolyte upon the activity of Clostridium perfringens sialidase toward sialyllactose and sialoglycolipids. J Biol Chem 1975,250(21),8462-8466
19. Shi M.; Wang J.; Bi F.; Bai Z.; Diosmetin alleviates cerebral ischemia-reperfusion injury through Keap1-mediated Nrf2/ARE signaling pathway activation and NLRP3 inflammasome inhibition. Environ Toxicol 2022,37(6),1529-1542 [DOI: 10.1002/tox.23504]
20. Mo G.; He Y.; Zhang X.; Lei X.; Luo Q.; Diosmetin exerts cardioprotective effect on myocardial ischaemia injury in neonatal rats by decreasing oxidative stress and myocardial apoptosis. Clin Exp Pharmacol Physiol 2020,47(10),1713-1722 [DOI: 10.1111/1440-1681.13309]
21. Yang K.; Li W.F.; Yu J.F.; Yi C.; Huang W.F.; Diosmetin protects against ischemia/reperfusion-induced acute kidney injury in mice. J Surg Res 2017,214,69-78 [DOI: 10.1016/j.jss.2017.02.067]
22. Wang C.; Liao Y.; Wang S.; Wang D.; Wu N.; Xu Q.; Jiang W.; Qiu M.; Liu C.; Cytoprotective effects of diosmetin against hydrogen peroxide-induced L02 cell oxidative damage via activation of the Nrf2-ARE signaling pathway. Mol Med Rep 2018,17(5),7331-7338 [DOI: 10.3892/mmr.2018.8750]
23. Bednarska K.; Fecka I.; Potential of vasoprotectives to inhibit non-enzymatic protein glycation, and reactive carbonyl and oxygen species uptake. Int J Mol Sci 2021,22(18),10026 [DOI: 10.3390/ijms221810026]
24. Zhang Y.; Jiang Y.; Lu D.; Diosmetin suppresses neuronal apoptosis and inflammation by modulating the phosphoinositide 3-kinase (PI3K)/AKT/Nuclear Factor-��B (NF-��B) signaling pathway in a rat model of pneumococcal meningitis. Med Sci Monit 2019,25,2238-2245 [DOI: 10.12659/MSM.911860]
25. Chen Y.; Peng F.; Xing Z.; Chen J.; Peng C.; Li D.; Beneficial effects of natural flavonoids on neuroinflammation. Front Immunol 2022,13,1006434 [DOI: 10.3389/fimmu.2022.1006434]
26. Uddin M.S.; Mamun A.A.; Rahman M.M.; Jeandet P.; Alexiou A.; Behl T.; Sarwar M.S.; Sobarzo-S��nchez E.; Ashraf G.M.; Sayed A.A.; Albadrani G.M.; Peluso I.; Abdel-Daim M.M.; Natural products for neurodegeneration: Regulating neurotrophic signals. Oxid Med Cell Longev 2021,2021,1-17 [DOI: 10.1155/2021/8820406]
27. Lai M.C.; Liu W.Y.; Liou S.S.; Liu I.M.; Diosmetin targeted at peroxisome proliferator-activated receptor gamma alleviates advanced glycation end products induced neuronal injury. Nutrients 2022,14(11),2248 [DOI: 10.3390/nu14112248]
28. Saeedi M.; Rashidy-Pour A.; Association between chronic stress and Alzheimer���s disease: Therapeutic effects of Saffron. Biomed Pharmacother 2021,133,110995 [DOI: 10.1016/j.biopha.2020.110995]
29. Saghaei E.; Nasiri Boroujeni S.; Safavi P.; Borjian Boroujeni Z.; Bijad E.; Diosmetin mitigates cognitive and memory impairment provoked by chronic unpredictable mild stress in mice. Evid Based Complement Alternat Med 2020,1-10 [DOI: 10.1155/2020/5725361]
30. Zhang L.; Li D.; Cao F.; Xiao W.; Zhao L.; Ding G.; Wang Z.; Identification of human acetylcholinesterase inhibitors from the constituents of egb761 by modeling docking and molecular dynamics simulations. Comb Chem High Throughput Screen 2018,21(1),41-49 [DOI: 10.2174/1386207320666171123201910]
31. Lucas K.; Rosch M.; Langguth P.; Molecular hydrogen (H ) as a potential treatment for acute and chronic fatigue. Arch Pharm 2021,354(4),2000378 [DOI: 10.1002/ardp.202000378]
32. Kaya Y.; Er��a�� A.; Zorlu Y.; Demir Y.; G��l��in ��.; New Pd(II) complexes of the bisthiocarbohydrazones derived from isatin and disubstituted salicylaldehydes: Synthesis, characterization, crystal structures and inhibitory properties against some metabolic enzymes. J Biol Inorg Chem 2022,27(2),271-281 [DOI: 10.1007/s00775-022-01932-9]
33. Assadieskandar A.; Yu C.; Maisonneuve P.; Kurinov I.; Sicheri F.; Zhang C.; Rigidification dramatically improves inhibitor selectivity for RAF kinases. ACS Med Chem Lett 2019,10(7),1074-1080 [DOI: 10.1021/acsmedchemlett.9b00194]
34. Oztaskin N.; Goksu S.; Demir Y.; Maras A.; Gulcin ��.; Synthesis of novel bromophenol with diaryl methanes���determination of their inhibition effects on carbonic anhydrase and acetylcholinesterase. Molecules 2022,27(21),7426 [DOI: 10.3390/molecules27217426]
35. Hong S.W.; Teesdale-Spittle P.; Page R.; Truman P.; A review of monoamine oxidase (MAO) inhibitors in tobacco or tobacco smoke. Neurotoxicology 2022,93,163-172 [DOI: 10.1016/j.neuro.2022.09.008]
36. Sher E.; Codignola A.; Biancardi E.; Cova D.; Clementi F.; Amine uptake inhibition by diosmin and diosmetin in human neuronal and neuroendocrine cell lines. Pharmacol Res 1992,26(4),395-402 [DOI: 10.1016/1043-6618(92)90238-7]
37. Rebas E.; Rzajew J.; Radzik T.; Zylinska L.; Neuroprotective polyphenols: A modulatory action on neurotransmitter pathways. Curr Neuropharmacol 2020,18(5),431-445 [DOI: 10.2174/1570159X18666200106155127]
38. Mei Z.; Du L.; Liu X.; Chen X.; Tian H.; Deng Y.; Zhang W.; Diosmetin alleviated cerebral ischemia/reperfusion injury in vivo and in vitro by inhibiting oxidative stress via the SIRT1/Nrf2 signaling pathway. Food Funct 2022,13(1),198-212 [DOI: 10.1039/D1FO02579A]
39. DeFronzo R.A.; Ferrannini E.; Groop L.; Henry R.R.; Herman W.H.; Holst J.J.; Hu F.B.; Kahn C.R.; Raz I.; Shulman G.I.; Simonson D.C.; Testa M.A.; Weiss R.; Type 2 diabetes mellitus. Nat Rev Dis Primers 2015,1(1),15019 [DOI: 10.1038/nrdp.2015.19]
40. Akda�� M.; ��z��elik A.B.; Demir Y.; Beydemir ��.; Design, synthesis, and aldose reductase inhibitory effect of some novel carboxylic acid derivatives bearing 2-substituted-6-aryloxo-pyridazinone moiety. J Mol Struct 2022,1258,132675 [DOI: 10.1016/j.molstruc.2022.132675]
41. Sever B.; Alt��ntop M.D.; Demir Y.; Y��lmaz N.; Akal��n ��ift��i G.; Beydemir ��.; ��zdemir A.; Identification of a new class of potent aldose reductase inhibitors: Design, microwave-assisted synthesis, in vitro and in silico evaluation of 2-pyrazolines. Chem Biol Interact 2021,345,109576 [DOI: 10.1016/j.cbi.2021.109576]
42. Gong X.; Xiong L.; Bi C.; Zhang B.; Diosmetin ameliorate type 2 diabetic mellitus by up-regulating Corynebacterium glutamicum to regulate IRS/PI3K/AKT-mediated glucose metabolism disorder in KK-Ay mice. Phytomedicine 2021,87,153582 [DOI: 10.1016/j.phymed.2021.153582]
43. Huang X.; Liu G.; Guo J.; Su Z.; The PI3K/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci 2018,14(11),1483-1496 [DOI: 10.7150/ijbs.27173]
44. Ononamadu C.; Ihegboro G.O.; Owolarafe T.A.; Salawu K.; Fadilu M.; Ezeigwe O.C.; Oshobu M.L.; Nwachukwu F.C.; Identification of potential antioxidant and hypoglycemic compounds in aqueous-methanol fraction of methanolic extract of ocimum canum leaves. Anal Bioanal Chem Res 2019,6(2),431-439 [DOI: 10.22036/abcr.2019.161326.1291]
45. Michael H.N.; Salib J.Y.; Eskander E.F.; Bioactivity of diosmetin glycosides isolated from the epicarp of date fruits, Phoenix dactylifera, on the biochemical profile of alloxan diabetic male rats. Phytother Res 2013,27(5),699-704 [DOI: 10.1002/ptr.4777]
46. St��l P.; Liver fibrosis in non-alcoholic fatty liver disease: Diagnostic challenge with prognostic significance. World J Gastroenterol 2015,21(39),11077-11087 [DOI: 10.3748/wjg.v21.i39.11077]
47. Zhang G.; Yan Y.; Feng X.; Effect of diosmetin on young rats with high-fat diet-induced non-alcoholic fatty liver disease. Trop J Pharm Res 2022,20(2),315-320 [DOI: 10.4314/tjpr.v20i2.14]
48. Luo N.; Yang C.; Zhu Y.; Chen Q.; Zhang B.; Diosmetin ameliorates nonalcoholic steatohepatitis through modulating lipogenesis and inflammatory response in a STAT1/ CXCL10-dependent manner. J Agric Food Chem 2021,69(2),655-667 [DOI: 10.1021/acs.jafc.0c06652]
49. Meephat S.; Prasatthong P.; Rattanakanokchai S.; Bunbupha S.; Maneesai P.; Pakdeechote P.; Diosmetin attenuates metabolic syndrome and left ventricular alterations via the suppression of angiotensin II/AT 1 receptor/gp /p-NF-��B protein expression in high-fat diet fed rats. Food Funct 2021,12(4),1469-1481 [DOI: 10.1039/D0FO02744H]
50. Sadeghi H.M.; Adeli I.; Calina D.; Docea A.O.; Mousavi T.; Daniali M.; Nikfar S.; Tsatsakis A.; Abdollahi M.; Polycystic Ovary syndrome: A comprehensive review of pathogenesis, management, and drug repurposing. Int J Mol Sci 2022,23(2),583 [DOI: 10.3390/ijms23020583]
51. Yan Y.; Liu X.; Gao J.; Wu Y.; Li Y.; Inhibition of TGF-�� signaling in gliomas by the flavonoid diosmetin isolated from Dracocephalum peregrinum L. Molecules 2020,25(1),192 [DOI: 10.3390/molecules25010192]
52. Ahmad T.; Khan T.; Kirabo A.; Shah A.J.; Antioxidant flavonoid diosmetin is cardioprotective in a rat model of myocardial infarction induced by beta 1-adrenergic receptors activation. Curr Issues Mol Biol 2023,45(6),4675-4686 [DOI: 10.3390/cimb45060297]
53. Zaragoz�� C.; ��lvarez-Mon M.��.; Zaragoz�� F.; Villaescusa L.; Flavonoids: Antiplatelet effect as inhibitors of COX-1. Molecules 2022,27(3),1146 [DOI: 10.3390/molecules27031146]
54. Zaragoz�� C.; Monserrat J.; Mantec��n C.; Villaescusa L.; ��lvarez-Mon M.��.; Zaragoz�� F.; ��lvarez-Mon M.; Binding and antiplatelet activity of quercetin, rutin, diosmetin, and diosmin flavonoids. Biomed Pharmacother 2021,141,111867 [DOI: 10.1016/j.biopha.2021.111867]
55. Guo Y.; Li D.; Cen X.; Qiu H.; Ma Y.; Liu Y.; Huang S.; Liu L.; Xu M.; Tang Q.Z.; Diosmetin protects against cardiac hypertrophy via p62/Keap1/Nrf2 signaling pathway. Oxid Med Cell Longev 2022,2022,1-14 [DOI: 10.1155/2022/8367997]
56. Wang H.; Zhang X.; Liu Y.; Zhang Y.; Wang Y.; Peng Y.; Ding Y.; Diosmetin-7-O-��-D-glucopyranoside suppresses endothelial���mesenchymal transformation through endoplasmic reticulum stress in cardiac fibrosis. Clin Exp Pharmacol Physiol 2023,50(10),789-805 [DOI: 10.1111/1440-1681.13802]
57. Arab H.H.; Salama S.A.; Omar H.A.; Arafa E.S.A.; Maghrabi I.A.; Diosmin protects against ethanol-induced gastric injury in rats: Novel anti-ulcer actions. PLoS One 2015,10(3),e0122417 [DOI: 10.1371/journal.pone.0122417]
58. Raffetto J.D.; Pathophysiology of chronic venous disease and venous ulcers. Surg Clin North Am 2018,98(2),337-347 [DOI: 10.1016/j.suc.2017.11.002]
59. Yu X.; Liu Y.; Diosmetin attenuate experimental ulcerative colitis in rats via suppression of NF-��B, TNF-�� and IL-6 signalling pathways correlated with down-regulation of apoptotic events. Eur J Inflamm 2021,19,. [DOI: 10.1177/20587392211067292]
60. Rabia A.; Muhammad U.I.; Nazia E.; Tayyaba A.; Ali A.; Houda A.; Nawaf W.A.; Suhail R.; Diosmetin alleviates nonylphenol-induced liver damage by improving biochemical, inflammatory, apoptotic, and histological profile in rats. J King Saud Univ Sci 2023,35(1),102392 [DOI: 10.1016/j.jksus.2022.10239]
61. W��jciak M.; Feldo M.; Borowski G.; Kubrak T.; P��achno B.J.; Sowa I.; Antioxidant potential of diosmin and diosmetin against oxidative stress in endothelial cells. Molecules 2022,27(23),8232 [DOI: 10.3390/molecules27238232]
62. Ge A.; Liu Y.; Zeng X.; Kong H.; Ma Y.; Zhang J.; Bai F.; Huang M.; Effect of diosmetin on airway remodeling in a murine model of chronic asthma. Acta Biochim Biophys Sin 2015,47(8),604-611 [DOI: 10.1093/abbs/gmv052]
63. Ge A.; Ma Y.; Liu Y.N.; Li Y.S.; Gu H.; Zhang J.X.; Wang Q.X.; Zeng X.N.; Huang M.; Diosmetin prevents TGF-��1-induced epithelial-mesenchymal transition via ROS/MAPK signaling pathways. Life Sci 2016,153,1-8 [DOI: 10.1016/j.lfs.2016.04.023]
64. Hao L.; Lu R.; Ma X.; Fan S.; Effect of diosmetin on acute lung injury induced by meconium and its mechanism in neonatal rats. Lab Anim Comp Med 2020,40(5),384 [DOI: 10.3969/j.issn.1674-5817.2020.05.004]
65. Liu Q.; Ci X.; Wen Z.; Peng L.; Diosmetin alleviates lipopolysaccharide-induced acute lung injury through activating the Nrf2 pathway and inhibiting the NLRP3 inflammasome. Biomol Ther 2018,26(2),157-166 [DOI: 10.4062/biomolther.2016.234]
66. Zhou B.; Wang L.; Yang S.; Liang Y.; Zhang Y.; Pan X.; Li J.; Diosmetin alleviates benzo[a]pyrene-exacerbated H1N1 influenza virus-induced acute lung injury and dysregulation of inflammation through modulation of the PPAR-��-NF-��B/P38 MAPK signaling axis. Food Funct 2023,14(7),3357-3378 [DOI: 10.1039/D2FO02590F]
67. Xia J.; Li J.; Deng M.; Yin F.; Liu J.; Wang J.; Diosmetin alleviates acute lung injury caused by lipopolysaccharide by targeting barrier function. Inflammopharmacology 2023,31(4),2037-2047 [DOI: 10.1007/s10787-023-01228-7]
68. Alqahtani M.J.; Negm W.A.; Saad H.M.; Salem E.A.; Hussein I.A.; Ibrahim H.A.; Fenofibrate and Diosmetin in a rat model of testicular toxicity: New insight on their protective mechanism through PPAR-��/NRF-2/HO-1 signaling pathway. Biomed Pharmacother 2023,165,115095 [DOI: 10.1016/j.biopha.2023.115095]
69. Chen Y.; Xiang Q.; Peng F.; Gao S.; Yu L.; Tang Y.; Yang Z.; Pu W.; Xie X.; Peng C.; The mechanism of action of safflower total flavonoids in the treatment of endometritis caused by incomplete abortion based on network pharmacology and 16S rDNA sequencing. J Ethnopharmacol 2023,315,116639 [DOI: 10.1016/j.jep.2023.116639]
70. Adamante G.; de Almeida A.S.; Rigo F.K.; da Silva Silveira E.; Coelho Y.O.; De Pr�� S.D.T.; Milioli A.M.; Camponogara C.; Casoti R.; Bellinaso F.; Desideri A.V.; Santos M.F.C.; Ferreira J.; Oliveira S.M.; Trevisan G.; Diosmetin as a novel transient receptor potential vanilloid 1 antagonist with antinociceptive activity in mice. Life Sci 2019,216,215-226 [DOI: 10.1016/j.lfs.2018.11.029]
71. Feldo M.; W��jciak M.; Ziemlewska A.; Dresler S.; Sowa I.; Modulatory effect of diosmin and diosmetin on metalloproteinase activity and inflammatory mediators in human skin fibroblasts treated with lipopolysaccharide. Molecules 2022,27(13),4264 [DOI: 10.3390/molecules27134264]
72. Chen Y.; Wang Y.; Liu M.; Zhou B.; Yang G.; Diosmetin exhibits anti-proliferative and anti-inflammatory effects on TNF-��-stimulated human rheumatoid arthritis fibroblast-like synoviocytes through regulating the Akt and NF-��B signaling pathways. Phytother Res 2020,34(6),1310-1319 [DOI: 10.1002/ptr.6596]
73. Yarmolinsky L.; Budovsky A.; Ben-Shabat S.; Khalfin B.; Gorelick J.; Bishitz Y.; Miloslavski R.; Yarmolinsky L.; Recent updates on the phytochemistry and pharmacological properties of Phlomis viscosa poiret. Rejuvenation Res 2019,22(4),282-288 [DOI: 10.1089/rej.2018.2093]
74. Ma A.; Zhang R.; Diosmetin inhibits cell proliferation, induces cell apoptosis and cell cycle arrest in liver cancer. Cancer Manag Res 2020,12,3537-3546 [DOI: 10.2147/CMAR.S240064]
75. Choi J.; Lee D.H.; Park S.Y.; Seol J.W.; Diosmetin inhibits tumor development and block tumor angiogenesis in skin cancer. Biomed Pharmacother 2019,117,109091 [DOI: 10.1016/j.biopha.2019.109091]
76. Zhao F.; Hong X.; Li D.; Wei Z.; Ci X.; Zhang S.; Diosmetin induces apoptosis in ovarian cancer cells by activating reactive oxygen species and inhibiting the Nrf2 pathway. Med Oncol 2021,38(5),54 [DOI: 10.1007/s12032-021-01501-1]
77. Meephat S.; Prasatthong P.; Potue P.; Bunbupha S.; Pakdeechote P.; Maneesai P.; Diosmetin ameliorates vascular dysfunction and remodeling by modulation of Nrf2/HO-1 and p-JNK/p-NF-��B expression in hypertensive rats. Antioxidants 2021,10(9),1487 [DOI: 10.3390/antiox10091487]
78. Ning R.; Chen G.; Fang R.; Zhang Y.; Zhao W.; Qian F.; Diosmetin inhibits cell proliferation and promotes apoptosis through STAT3/c-Myc signaling pathway in human osteosarcoma cells. Biol Res 2021,54(1),40 [DOI: 10.1186/s40659-021-00363-1]
79. Oak C.; Khalifa A.; Isali I.; Bhaskaran N.; Walker E.; Shukla S.; Diosmetin suppresses human prostate cancer cell proliferation through the induction of apoptosis and cell cycle arrest. Int J Oncol 2018,53(2),835-843 [DOI: 10.3892/ijo.2018.4407]
80. Liu S.; Zhou X.; Li W.; Zhang H.; Zhang B.; Li G.; Liu B.; Deng X.; Peng L.; Diosmetin inhibits the expression of alpha-hemolysin in Staphylococcus aureus. Antonie van Leeuwenhoek 2015,108(2),383-389 [DOI: 10.1007/s10482-015-0491-6]
81. Chan B.C.L.; Ip M.; Gong H.; Lui S.L.; See R.H.; Jolivalt C.; Fung K.P.; Leung P.C.; Reiner N.E.; Lau C.B.S.; Synergistic effects of diosmetin with erythromycin against ABC transporter over-expressed methicillin-resistant Staphylococcus aureus (MRSA) RN4220/pUL5054 and inhibition of MRSA pyruvate kinase. Phytomedicine 2013,20(7),611-614 [DOI: 10.1016/j.phymed.2013.02.007]
82. Wang S.Y.; Sun Z.L.; Liu T.; Gibbons S.; Zhang W.J.; Qing M.; Flavonoids from Sophora moorcroftiana and their synergistic antibacterial effects on MRSA. Phytother Res 2014,28(7),1071-1076 [DOI: 10.1002/ptr.5098]
83. Liu Y.; Benohoud M.; Galani Yamdeu J.H.; Gong Y.Y.; Orfila C.; Green extraction of polyphenols from citrus peel by-products and their antifungal activity against Aspergillus flavus. Food Chem X 2021,12,100144 [DOI: 10.1016/j.fochx.2021.100144]
84. Yang S.; Wang L.; Pan X.; Liang Y.; Zhang Y.; Li J.; Zhou B.; 5-Methoxyflavone-induced AMPK�� activation inhibits NF-��B and P38 MAPK signaling to attenuate influenza A virus-mediated inflammation and lung injury in vitro and in vivo. Cell Mol Biol Lett 2022,27(1),82 [DOI: 10.1186/s11658-022-00381-1]
85. Anwer M.K.; Aldawsari M.F.; Iqbal M.; Almutairy B.K.; Soliman G.A.; Aboudzadeh M.A.; Diosmin-loaded nanoemulsion-based gel formulation: Development, optimization, wound healing and anti-inflammatory studies. Gels 2023,9(2),95 [DOI: 10.3390/gels9020095]
86. Hsu Y.L.; Kuo P.L.; Diosmetin induces human osteoblastic differentiation through the protein kinase C/p38 and extracellular signal-regulated kinase 1/2 pathway. J Bone Miner Res 2008,23(6),949-960 [DOI: 10.1359/jbmr.080219]
87. Ding H.; Ding H.; Mu P.; Lu X.; Xu Z.; Diosmetin inhibits subchondral bone loss and indirectly protects cartilage in a surgically-induced osteoarthritis mouse model. Chem Biol Interact 2023,370,110311 [DOI: 10.1016/j.cbi.2022.110311]
88. Shao S.; Fu F.; Wang Z.; Song F.; Li C.; Wu Z.; Ding J.; Li K.; Xiao Y.; Su Y.; Lin X.; Yuan G.; Zhao J.; Liu Q.; Xu J.; Diosmetin inhibits osteoclast formation and differentiation and prevents LPS-induced osteolysis in mice. J Cell Physiol 2019,234(8),12701-12713 [DOI: 10.1002/jcp.27887]
89. Park N.J.; Jo B.G.; Bong S.K.; Park S.; Lee S.; Kim Y.K.; Yang M.H.; Kim S.N.; Lobelia chinensis extract and its active compound, diosmetin, improve atopic dermatitis by reinforcing skin barrier function through SPINK5/LEKTI regulation. Int J Mol Sci 2022,23(15),8687 [DOI: 10.3390/ijms23158687]
90. Park S.; Bong S.K.; Lee J.W.; Park N.J.; Choi Y.; Kim S.M.; Yang M.H.; Kim Y.K.; Kim S.N.; Diosmetin and its glycoside, diosmin, improve atopic dermatitis like lesions in 2,4-dinitrochlorobenzene-induced murine models. Biomol Ther 2020,28(6),542-548 [DOI: 10.4062/biomolther.2020.135]
91. Shen Z.; Shao J.; Dai J.; Lin Y.; Yang X.; Ma J.; He Q.; Yang B.; Yao K.; Luo P.; Diosmetin protects against retinal injury via reduction of DNA damage and oxidative stress. Toxicol Rep 2016,3,78-86 [DOI: 10.1016/j.toxrep.2015.12.004]
92. Guo G.; Dong J.; Diosmetin attenuates oxidative stress-induced damage to lens epithelial cells via the mitogen-activated protein kinase (MAPK) pathway. Bioengineered 2022,13(4),11072-11081 [DOI: 10.1080/21655979.2022.2068755]
93. Sawmiller D.; Habib A.; Li S.; Darlington D.; Hou H.; Tian J.; Shytle R.D.; Smith A.; Giunta B.; Mori T.; Tan J.; Diosmin reduces cerebral A�� levels, tau hyperphosphorylation, neuroinflammation, and cognitive impairment in the 3xTg-AD mice. J Neuroimmunol 2016,299,98-106 [DOI: 10.1016/j.jneuroim.2016.08.018]
94. Boisnic S.; Branchet M.C.; Quioc-Salomon B.; Doan J.; Delva C.; Gendron C.; Anti-inflammatory and antioxidant effects of diosmetin-3-O-��-d-glucuronide, the main metabolite of diosmin: Evidence from ex vivo human skin models. Molecules 2023,28(14),5591 [DOI: 10.3390/molecules28145591]
95. Yang Y.; Gong X.B.; Huang L.G.; Wang Z.X.; Wan R.Z.; Zhang P.; Zhang Q.Y.; Chen Z.; Zhang B.S.; Diosmetin exerts anti-oxidative, anti-inflammatory and anti-apoptotic effects to protect against endotoxin-induced acute hepatic failure in mice. Oncotarget 2017,8(19),30723-30733 [DOI: 10.18632/oncotarget.15413]
96. Guzik T.J.; Harrison D.G.; Endothelial NF-kappaB as a mediator of kidney damage: The missing link between systemic vascular and renal disease? Circ Res 2007,101(3),227-229 [DOI: 10.1161/CIRCRESAHA.107.158295]
97. Yu G.; Wan R.; Yin G.; Xiong J.; Hu Y.; Xing M.; Cang X.; Fan Y.; Xiao W.; Qiu L.; Wang X.; Hu G.; Diosmetin ameliorates the severity of cerulein-induced acute pancreatitis in mice by inhibiting the activation of the nuclear factor-��B. Int J Clin Exp Pathol 2014,7(5),2133-2142 [PMID: 24966921]
98. Russo R.; Chandradhara D.; De Tommasi N.; Comparative bioavailability of two diosmin formulations after oral administration to healthy volunteers. Molecules 2018,23(9),2174 [DOI: 10.3390/molecules23092174]
99. Mandal P.; Dan S.; Chakraborty S.; Ghosh B.; Saha C.; Khanam J.; Pal T.K.; Simultaneous determination and quantitation of diosmetin and hesperetin in human plasma by liquid chromatographic mass spectrometry with an application to pharmacokinetic studies. J Chromatogr Sci 2019,57(5),451-461 [DOI: 10.1093/chromsci/bmz015]
100. Chen X.; Xu L.; Guo S.; Wang Z.; Jiang L.; Wang F.; Zhang J.; Liu B.; Profiling and comparison of the metabolites of diosmetin and diosmin in rat urine, plasma and feces using UHPLC-LTQ-Orbitrap MS. J Chromatogr B Analyt Technol Biomed Life Sci 2019,1124,58-71 [DOI: 10.1016/j.jchromb.2019.05.030]
101. Hollman P.C.H.; Bioavailability, and metabolism of flavonoids. A. Pharma Biol 2009,42(1),74-83 [DOI: 10.3109/13880200490893492]
102. Sil S.; Das A.; Seal I.; Mukherjee S.; Roy S.; A toxicological evaluation for safety assessment of ruthenium-based diosmetin complex in rats. Regul Toxicol Pharmacol 2023,137,105303 [DOI: 10.1016/j.yrtph.2022.105303]

MeSH Term

Chemicals